The risk of anemia following transplantation is compounded by immunosuppression with mTOR inhibitors [46, 49–51] or mycophenolic acid [46, 52, 53], although this effect is less marked in the presence of higher GFR [54]. This evidence concerns the gene MTOR and anemia (phenotype).